23andMe cofounder says company ‘lost its way’ without ‘proper governance’
23andMe cofounder Linda Avey is mourning what the biotech company could have become. The company filed for Chapter 11 bankruptcy protection on Sunday.
Digital assets group outlines blockchain policy goals
https://www.foxbusiness.com/technology/digital-assets-group-outlines-blockchain-policy-goals
Consumer expectations for future plunge to 12-year low on tariff anxiety
https://www.cfodive.com/news/consumer-expectations-future-plunge-12-year-low-tariff-anxiety-Trump-inflation-Fed-Powell/743499/
‘Studio Ghibli’ AI image trend overwhelms OpenAI’s new GPT-4o feature, delaying free tier
The new feature has been widely embraced by users of X, but it raises copyright concerns and goes against Studio Ghibli’s creator.
See photos of Camp Century, a secret US military base built beneath Greenland’s ice sheet
Camp Century was built to store nukes beneath Greenland’s ice. See photos of the underground, “Star Wars"-like site.
Comcast Corporation (CMCSA) New Street Research and BCG Future of Connectivity Leaders Conference (Transcript)
https://seekingalpha.com/article/4770701-comcast-corporation-cmcsa-new-street-research-and-bcg-future-of-connectivity-leaders
Verint Systems Inc. 2025 Q4 – Results – Earnings Call Presentation
https://seekingalpha.com/article/4770702-verint-systems-inc-2025-q4-results-earnings-call-presentation
Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4770703-journey-medical-corporation-derm-q4-2024-earnings-call-transcript
Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential
Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of Feb. 19, 2025. The video was published on March 26, 2025.Continue readinghttps://www.fool.com/investing/2025/03/26/neurocrine-biosciences-a-smart-biotech-bet-with-bl/
Googlers grilled leaders about smaller pay bumps in a recent all-hands
At a recent Google all-hands meeting, employees question leadership on 2025 compensation packages.